SurGenTec Secures FDA Clearance for ION-C™ - Now Navigation Compatible
SurGenTec, LLC, a leader in innovative spine and orthopedic technologies, today announced that the U.S. Food and Drug Administration (FDA) has granted 510(k)
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260529194913/en/ SurGenTec Announces FDA Clearance of ION-C™ Navigation for Real-Time Guidance in Posterior Cervical Facet Procedures
SurGenTec, LLC, a leader in innovative spine and orthopedic technologies, today announced that the U.S. Food and Drug Administration (FDA) has granted 510(k) clearance for its ION-C™ navigation instruments for use with the ION-C™ posterior cervical facet fixation implant. The system is engineered for compatibility with Medtronic’s StealthStation™ navigation platform, enabling enhanced precision during posterior cervical fusion procedures.
Designed to support enhanced procedural accuracy and engineered for compatibility with navigation, the ION-C™ navigation instruments are intended to assist surgeons in precisely locating anatomical structures — specifically the cervical facet joint — during open or minimally invasive spinal procedures to support implant placement and surgical workflow efficiency.
